APO RESEARCH · REPORT
Veterinary Vaccine
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Product & engineering
Understand the product.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Selected research
Industry Research
Veterinary Vaccine Industry Research Report 2026
Market perspective
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Vaccine Market by Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
BioTestLab
RVSRI
Medion
Veterinary Vaccine Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Others
Veterinary Vaccine Segment by Application
Livestock
Swine
Chicken
Dog & Cat
Others
Veterinary Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
Applications
- Livestock
- Swine
- Chicken
- Dog & Cat
- Others
Companies covered
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- BioTestLab
- RVSRI
- Medion
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Vaccine Market Size (2021-2032)
- 2.2.2 Global Veterinary Vaccine Sales (2021-2032)
- 2.2.3 Global Veterinary Vaccine Market Average Price (2021-2032)
- 2.3 Veterinary Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Live Attenuated Vaccines
- 2.3.3 Inactivated Vaccines
- 2.3.4 Others
- 2.4 Veterinary Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Livestock
- 2.4.3 Swine
- 2.4.4 Chicken
- 2.4.5 Dog & Cat
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Vaccine Sales (M Doses) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Veterinary Vaccine, Established Date
- 3.9 Global Veterinary Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Veterinary Vaccine Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Zoetis
- 4.2.1 Zoetis Company Information
- 4.2.2 Zoetis Business Overview
- 4.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zoetis Veterinary Vaccine Product Portfolio
- 4.2.5 Zoetis Recent Developments
- 4.3 Boehringer Ingelheim
- 4.3.1 Boehringer Ingelheim Company Information
- 4.3.2 Boehringer Ingelheim Business Overview
- 4.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
- 4.3.5 Boehringer Ingelheim Recent Developments
- 4.4 Ceva
- 4.4.1 Ceva Company Information
- 4.4.2 Ceva Business Overview
- 4.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ceva Veterinary Vaccine Product Portfolio
- 4.4.5 Ceva Recent Developments
- 4.5 CAHIC
- 4.5.1 CAHIC Company Information
- 4.5.2 CAHIC Business Overview
- 4.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CAHIC Veterinary Vaccine Product Portfolio
- 4.5.5 CAHIC Recent Developments
- 4.6 HVRI
- 4.6.1 HVRI Company Information
- 4.6.2 HVRI Business Overview
- 4.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 HVRI Veterinary Vaccine Product Portfolio
- 4.6.5 HVRI Recent Developments
- 4.7 Ringpu Biology
- 4.7.1 Ringpu Biology Company Information
- 4.7.2 Ringpu Biology Business Overview
- 4.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
- 4.7.5 Ringpu Biology Recent Developments
- 4.8 Yebio
- 4.8.1 Yebio Company Information
- 4.8.2 Yebio Business Overview
- 4.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Yebio Veterinary Vaccine Product Portfolio
- 4.8.5 Yebio Recent Developments
- 4.9 DHN
- 4.9.1 DHN Company Information
- 4.9.2 DHN Business Overview
- 4.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 DHN Veterinary Vaccine Product Portfolio
- 4.9.5 DHN Recent Developments
- 4.10 WINSUN
- 4.10.1 WINSUN Company Information
- 4.10.2 WINSUN Business Overview
- 4.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 WINSUN Veterinary Vaccine Product Portfolio
- 4.10.5 WINSUN Recent Developments
- 4.11 Elanco
- 4.11.1 Elanco Company Information
- 4.11.2 Elanco Business Overview
- 4.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Elanco Veterinary Vaccine Product Portfolio
- 4.11.5 Elanco Recent Developments
- 4.12 Virbac
- 4.12.1 Virbac Company Information
- 4.12.2 Virbac Business Overview
- 4.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Virbac Veterinary Vaccine Product Portfolio
- 4.12.5 Virbac Recent Developments
- 4.13 Jinyu Bio-Technology
- 4.13.1 Jinyu Bio-Technology Company Information
- 4.13.2 Jinyu Bio-Technology Business Overview
- 4.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
- 4.13.5 Jinyu Bio-Technology Recent Developments
- 4.14 ChengDu Tecbond
- 4.14.1 ChengDu Tecbond Company Information
- 4.14.2 ChengDu Tecbond Business Overview
- 4.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
- 4.14.5 ChengDu Tecbond Recent Developments
- 4.15 CAVAC
- 4.15.1 CAVAC Company Information
- 4.15.2 CAVAC Business Overview
- 4.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 CAVAC Veterinary Vaccine Product Portfolio
- 4.15.5 CAVAC Recent Developments
- 4.16 Kyoto Biken Laboratories
- 4.16.1 Kyoto Biken Laboratories Company Information
- 4.16.2 Kyoto Biken Laboratories Business Overview
- 4.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
- 4.16.5 Kyoto Biken Laboratories Recent Developments
- 4.17 FATRO
- 4.17.1 FATRO Company Information
- 4.17.2 FATRO Business Overview
- 4.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 FATRO Veterinary Vaccine Product Portfolio
- 4.17.5 FATRO Recent Developments
- 4.18 Vaksindo
- 4.18.1 Vaksindo Company Information
- 4.18.2 Vaksindo Business Overview
- 4.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Vaksindo Veterinary Vaccine Product Portfolio
- 4.18.5 Vaksindo Recent Developments
- 4.19 Bio-Labs
- 4.19.1 Bio-Labs Company Information
- 4.19.2 Bio-Labs Business Overview
- 4.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
- 4.19.5 Bio-Labs Recent Developments
- 4.20 Avimex Animal Health
- 4.20.1 Avimex Animal Health Company Information
- 4.20.2 Avimex Animal Health Business Overview
- 4.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
- 4.20.5 Avimex Animal Health Recent Developments
- 4.21 MEVAC
- 4.21.1 MEVAC Company Information
- 4.21.2 MEVAC Business Overview
- 4.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 MEVAC Veterinary Vaccine Product Portfolio
- 4.21.5 MEVAC Recent Developments
- 4.22 Biovac
- 4.22.1 Biovac Company Information
- 4.22.2 Biovac Business Overview
- 4.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Biovac Veterinary Vaccine Product Portfolio
- 4.22.5 Biovac Recent Developments
- 4.23 Atafen
- 4.23.1 Atafen Company Information
- 4.23.2 Atafen Business Overview
- 4.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Atafen Veterinary Vaccine Product Portfolio
- 4.23.5 Atafen Recent Developments
- 4.24 Dyntec
- 4.24.1 Dyntec Company Information
- 4.24.2 Dyntec Business Overview
- 4.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.24.4 Dyntec Veterinary Vaccine Product Portfolio
- 4.24.5 Dyntec Recent Developments
- 4.25 BioTestLab
- 4.25.1 BioTestLab Company Information
- 4.25.2 BioTestLab Business Overview
- 4.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.25.4 BioTestLab Veterinary Vaccine Product Portfolio
- 4.25.5 BioTestLab Recent Developments
- 4.26 RVSRI
- 4.26.1 RVSRI Company Information
- 4.26.2 RVSRI Business Overview
- 4.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.26.4 RVSRI Veterinary Vaccine Product Portfolio
- 4.26.5 RVSRI Recent Developments
- 4.27 Medion
- 4.27.1 Medion Company Information
- 4.27.2 Medion Business Overview
- 4.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.27.4 Medion Veterinary Vaccine Product Portfolio
- 4.27.5 Medion Recent Developments
5 Global Veterinary Vaccine Market Scenario by Region
- 5.1 Global Veterinary Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Vaccine Sales by Region: 2027-2032
- 5.3 Global Veterinary Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Vaccine Revenue by Region: 2027-2032
- 5.4 North America Veterinary Vaccine Market Facts & Figures by Country
- 5.4.1 North America Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Veterinary Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Veterinary Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Vaccine Market Facts & Figures by Country
- 5.7.1 South America Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Veterinary Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Vaccine Sales by Type (2021-2032) & (M Doses)
- 6.1.2 Global Veterinary Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Vaccine Sales by Application (2021-2032) & (M Doses)
- 7.1.2 Global Veterinary Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Vaccine Value Chain Analysis
- 8.1.1 Veterinary Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Vaccine Production Mode & Process
- 8.2 Veterinary Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Vaccine Distributors
- 8.2.3 Veterinary Vaccine Customers
9 Global Veterinary Vaccine Analyzing Market Dynamics
- 9.1 Veterinary Vaccine Industry Trends
- 9.2 Veterinary Vaccine Industry Drivers
- 9.3 Veterinary Vaccine Industry Opportunities and Challenges
- 9.4 Veterinary Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst